Navigation Links
The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions

Sentry to Store and Distribute 500,000 Doses of the CDC's National

Strategic Reserve of the Influenza Virus Vaccine

INDIANAPOLIS, Feb. 11 /PRNewswire/ -- Sentry Logistic Solutions announced today that The Centers for Disease Control & Prevention (CDC) signed a contract to outsource storage and distribution of its national strategic reserve of the influenza virus vaccine. Sentry will warehouse and distribute more than 500,000 vaccine doses from its pharmaceutical cold chain logistics center. The company will benefit from its vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products. Ensuring product integrity, supply chain security and fast, efficient distribution is critical in the storage and dispersal of disease-preventing vaccines.

"Sentry's vaccine storage and distribution services were developed in an effort to help government entities, hospitals and public health care agencies make the proper storage arrangements for their vaccine stockpiles as they prepare for the winter immunization season," said Jennifer Marcum, Sentry's chief executive officer. "The opportunity to provide this service to The Centers for Disease Control & Prevention validates the value that we bring organizations that require highly specialized cold chain management programs for their drug products."

Sentry's vaccine storage and distribution service was specifically designed to protect the efficacy of vaccine inventories throughout the supply chain. The company has the expertise, facility, personnel and protocols to securely store, accurately track and quickly transport vaccines anywhere in the continental United States. Sentry's third-party logistics (3PL) services are ideally suited for state and federal health organizations' distribution and pandemic response plans for managing vaccine and biologic strategic reserves. Sentry's facility, systems and processes meet the CDC's recommendations for proper vaccine storage and handling procedures ( Additionally, the company holds the appropriate local, state and federal licenses and accreditations for safely handling and transporting regulated drug products.

Organizations that utilize Sentry's vaccine storage and distribution services receive many benefits including:

-- Assurance that vaccine storage and supply chain systems are secure,

meet specific temperature requirements and are CDC-compliant;

-- End-to-end logistics assistance, significantly compressing the

timetable to distribute vaccines to multiple sites;

-- Advanced inventory management systems that document the vaccines'

entire chain of custody and track the drugs' temperature history as

well as product receipts, shipments and expiration dates;

-- Rapid response to public health crises such as disease outbreaks,

vaccine shortages and disruption of the vaccine supply; and

-- Flexible short-term, long-term, emergency and contingency vaccine

storage, logistics and distribution programs as well as fully

outsourced supply chain solutions.

About Sentry Logistic Solutions

Sentry Logistic Solutions is one of the few cGMP temperature-controlled storage and third party logistics (3PL) providers in the United States to exclusively serve the global pharmaceutical, biotechnology and health care industries. Its facilities, infrastructure and services are specifically designed to meet the warehousing, packaging and logistics needs of pharma and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and government entities.

Sentry's management team offers expertise in cold chain storage and logistics, quality assurance, pharmaceutical packaging and kitting development. Sentry also offers strategic solutions for domestic and international transportation and logistics as well as end-to-end import and export management. The company's validated processes and inventory tracking systems are FDA compliant, adhere to Good Manufacturing Practice (GMP) and comply with stringent standard operating procedures (SOP) outlined in Sentry's Validation Master Plan. Sentry is VAWD(R) accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Board of Pharmacy(R). The company is privately- held and strategically headquartered in Indianapolis, Ind. For more information about the company, please visit or call (866) 757-7400.

Rachel Edwards Amy Zucker

Synergy Marketing Group, Inc. Synergy Marketing Group, Inc.

(317) 205-9690 ext. 227 (317) 205-9690 ext. 223

SOURCE Sentry Logistic Solutions
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance
2. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
3. Flurizans Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimers Disease is Superior to That of Aricept
4. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
5. Eisai/Pfizers Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimers Disease
6. Historic Breakthrough in Fighting Childrens Batten Disease as China Stem Cells Give New Lease on Life to 6 Year Old California Boy
7. AMTs Lead Product Poised to Address Major Liver Disease
8. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
9. UCB Crohns Scholarship Program to Award $300,000 to Students with Crohns Disease
10. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
11. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... November 24, 2015 SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
Breaking Biology News(10 mins):